REFERENCES
- Butterworth, M., McClellan, B., & Allansmith, M. (1967). Influence of sex in immunoglobulin levels. Nature, 214(5094), 1224–1225.
- Conti-Fine, B.M., Milani, M., & Kaminski, H.J. (2006). Myasthenia gravis: Past, present, and future. The Journal of Clinical Investigation, 116(11), 2843–2854.
- Hamano, H., Kawa, S., Horiuchi, A., Unno, H., Furuya, N., & Akamatsu, T., (2001). High serum IgG4 concentrations in patients with sclerosing pancreatitis. The New England Journal of Medicine, 344(10), 732–738.
- Kawano, Y., Noma, T., & Yata, J. (1994). Regulation of human IgG subclass production by cytokines: IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. The Journal of Immunology, 153(11), 4948–4958.
- Libert, C., Dejager, L., & Pinheiro, I. (2010). The X chromosome in immune functions: When a chromosome makes the difference. Nature Reviews Immunology, 10(8), 594–604.
- Meriggioli, M. N., & Sanders, D. B. (2009). Autoimmune myasthenia gravis: Emerging clinical and biological heterogeneity. The Lancet Neurology, 8(5), 475–490.
- Moiola, L., Karachunski, P., Protti, M. P, Howard, J. F. Jr, & Conti-Tronconi, B. M. (1994). Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4 +cells of myasthenia gravis patients and healthy subjects. The Journal of Clinical Investigation, 93(3), 1020–1028.
- Niks, E. H., van Leeuwen, Y., Leite, M. I., Dekker, F. W., Wintzen, A. R., Wirtz, P. W, (2008). Clinical fluctuations in MuSK myasthenia gravis are related to antigen-specific IgG4 instead of IgG1. Journal of Neuroimmunology, 195(1–2), 151– 156.
- Osserman, K. E., & Genkins, G. (1971). Studies in myasthenia gravis: Review of a twenty year experience in over 1200 patients. Mount Sinai Journal of Medicine, 38(6), 497–537.
- Rødgaard, A., Nielsen, F. C., Djurup, R., Somnier, F., & Gammeltoft, S. (1987). Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclasses 1 and 3. Clinical & Experimental Immunology, 67(1), 82–88.
- Romi, F., Skeie, G. O., Vedeler, C., Aarli, J. A., Zorzato, F., & Gilhus, N. E. (2000). Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis: A study of IgG subclasses and clinical correlations. Journal of Neuroimmunology, 111(1–2), 169–176.
- Tao, M. H., Smith, R. I., & Morrison, S. L. (1993). Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. Journal of Experimental Medicine, 178(2), 661–667.
- Woof, J. M., & Burton, D. R. (2004). Human antibody-Fc receptor interactions illuminated by crystal structures. Nature Reviews Immunology, 4(2), 89–99.